MSCM
PFE icon

McElhenny Sheffield Capital Management’s Pfizer PFE Stock Holding History

McElhenny Sheffield Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$357K Buy
14,807
+1,108
+8% +$29K 0.09% 57
2026
Q1 		$385K Buy
13,699
+707
+5% +$18.8K 0.1% 45
2025
Q4 		$323K Sell
12,992
-4,224
-25% -$107K 0.08% 70
2025
Q3 		$439K Buy
17,216
+619
+4% +$15.3K 0.1% 58
2025
Q2 		$402K Sell
16,597
-2
-0% -$47 0.11% 72
2025
Q1 		$421K Sell
16,599
-1,032
-6% -$27K 0.16% 68
2024
Q4 		$468K Buy
17,631
+1,114
+7% +$30.2K 0.16% 56
2024
Q3 		$478K Buy
16,517
+20
+0.1% +$583 0.16% 60
2024
Q2 		$462K Sell
16,497
-2
-0% -$55 0.16% 60
2024
Q1 		$458K Hold
16,499
– – 0.16% 59
2023
Q4 		$475K Hold
16,499
– – 0.19% 53
2023
Q3 		$547K Hold
16,499
– – 0.28% 43
2023
Q2 		$605K Sell
16,499
-32
-0.2% -$1.25K 0.26% 46
2023
Q1 		$674K Buy
16,531
+203
+1% +$8.77K 0.36% 52
2022
Q4 		$837K Sell
16,328
-26
-0.2% -$1.25K 0.39% 33
2022
Q3 		$716K Hold
16,354
– – 0.55% 37
2022
Q2 		$857K Sell
16,354
-20
-0.1% -$1.02K 0.4% 31
2022
Q1 		$848K Buy
16,374
+11
+0.1% +$571 0.3% 47
2021
Q4 		$966K Sell
16,363
-539
-3% -$26.7K 0.36% 40
2021
Q3 		$727K Buy
+16,902
New +$749K 0.33% 48

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

McElhenny Sheffield Capital Management's PFE Position: Q2 2026 in Review

McElhenny Sheffield Capital Management increased its Pfizer (PFE) stake by 8.1% in Q2 2026, buying an estimated $29K and bringing the position to 14,807 shares worth $357K. The position accounts for 0.09% of the portfolio, ranked #57.

McElhenny Sheffield Capital Management first reported a position in PFE in Q3 2021 and has held it in 20 quarters since. The position peaked at $966K in Q4 2021. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • McElhenny Sheffield Capital Management held 14,807 shares of Pfizer worth $357K as of Q2 2026.
  • McElhenny Sheffield Capital Management bought 1,108 Pfizer shares in Q2 2026, an estimated $29K.
  • Pfizer made up 0.09% of McElhenny Sheffield Capital Management's portfolio in Q2 2026, its #57 holding.
  • McElhenny Sheffield Capital Management first reported a position in Pfizer in Q3 2021 and has held it in 20 quarters since.
  • McElhenny Sheffield Capital Management's Pfizer position peaked at $966K in Q4 2021.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on McElhenny Sheffield Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.